Tegsedi-Induced Warm Antibody Autoimmune Hemolytic Anemia
Autoimmune hemolytic anemia is a hemolytic disorder in which antibodies attack erythrocytes, causing their destruction. Many medications have been linked to autoimmune hemolytic anemia, such as antibiotics, chemotherapy agents, and nonsteroidal anti-inflammatory drugs. Inotersen (Tegsedi [Sobi]) is...
Saved in:
| Main Authors: | Mariela Di Vanna, Nawal Aamir, Cristina Rodriguez Andujar, Adam Kaplan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2024-05-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2023.1147 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recurrent COVID-19 induced Warm Autoimmune Hemolytic Anemia
by: Mohammed Abu-Rumaileh, et al.
Published: (2025-06-01) -
Immunotherapy Treatments of Warm Autoimmune Hemolytic Anemia
by: Bainan Liu, et al.
Published: (2013-01-01) -
Autoimmune hemolytic anemia with warm antibodies in children: retrospective analysis of 51 cases
by: A Gürgey, et al.
Published: (1999-10-01) -
Advances in Immunotargeted Therapy for Warm Autoimmune Hemolytic Anemia
by: WANG Qi, et al.
Published: (2025-02-01) -
Dermoid Cysts and Refractory Warm Autoimmune Hemolytic Anemia in Pregnancy
by: Mohammad Alhomoud, et al.
Published: (2023-08-01)